Aarey Drugs & Pharmaceuticals Limited


Prices are adjusted according to historical splits.

Aarey Drugs & Pharmaceuticals Limited Stock Price


Today's Low:
Today's High:
Open Price:
52W Low:
52W High:
Prev. Close:

Company Statistics

Market Cap.:
₹695.69 million
Book Value:
Revenue TTM:
₹2.46 billion
Operating Margin TTM:
Gross Profit TTM:
₹99.07 million
Profit Margin:
Return on Assets TTM:
Return on Equity TTM:

Company Profile

Aarey Drugs & Pharmaceuticals Limited had its IPO on under the ticker symbol 524412.

The company operates in the Other sector and Other industry. Aarey Drugs & Pharmaceuticals Limited has a staff strength of 0 employees.

Stock update

Shares of Aarey Drugs & Pharmaceuticals Limited opened at ₹50.66 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹48.5 - ₹50.66, and closed at ₹48.5.

This is a -4.26% slip from the previous day's closing price.

A total volume of 10,587 shares were traded at the close of the day’s session.

In the last one week, shares of Aarey Drugs & Pharmaceuticals Limited have slipped by -3.39%.

Aarey Drugs & Pharmaceuticals Limited's Key Ratios

Aarey Drugs & Pharmaceuticals Limited has a market cap of ₹695.69 million, indicating a price to book ratio of 0.646 and a price to sales ratio of 0.1779.

In the last 12-months Aarey Drugs & Pharmaceuticals Limited’s revenue was ₹2.46 billion with a gross profit of ₹99.07 million and an EBITDA of ₹36.31 million. The EBITDA ratio measures Aarey Drugs & Pharmaceuticals Limited's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Aarey Drugs & Pharmaceuticals Limited’s operating margin was 1.1% while its return on assets stood at 0% with a return of equity of 0%.

In Q3, Aarey Drugs & Pharmaceuticals Limited’s quarterly earnings growth was a positive 43.5% while revenue growth was a negative 17.6%.

Aarey Drugs & Pharmaceuticals Limited’s PE and PEG Ratio

Forward PE
Trailing PE

Its diluted EPS in the last 12-months stands at ₹2.481 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Aarey Drugs & Pharmaceuticals Limited’s profitability.

Aarey Drugs & Pharmaceuticals Limited stock is trading at a EV to sales ratio of 0.2114 and a EV to EBITDA ratio of 6.1794. Its price to sales ratio in the trailing 12-months stood at 0.1779.

Aarey Drugs & Pharmaceuticals Limited stock pays annual dividends of per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
₹2.91 billion
Total Liabilities
₹1.68 billion
Operating Cash Flow
₹4.41 million
Capital Expenditure
₹10.44 million
Dividend Payout Ratio

Aarey Drugs & Pharmaceuticals Limited ended 2023 with ₹2.91 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹2.91 billion while shareholder equity stood at ₹1.17 billion.

Aarey Drugs & Pharmaceuticals Limited ended 2023 with ₹0 in deferred long-term liabilities, ₹1.68 billion in other current liabilities, 253847000.00 in common stock, ₹920.24 million in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹7.06 million and cash and short-term investments were ₹11.24 million. The company’s total short-term debt was ₹0 while long-term debt stood at ₹43.61 million.

Aarey Drugs & Pharmaceuticals Limited’s total current assets stands at ₹2.71 billion while long-term investments were ₹0 and short-term investments were ₹4.18 million. Its net receivables were ₹1.90 billion compared to accounts payable of ₹0 and inventory worth ₹288.19 million.

In 2023, Aarey Drugs & Pharmaceuticals Limited's operating cash flow was ₹4.41 million while its capital expenditure stood at ₹10.44 million.

Comparatively, Aarey Drugs & Pharmaceuticals Limited paid ₹0 in dividends in 2023.

Other key metrics

Current Trading Price
52-Week High
52-Week Low
Analyst Target Price

Aarey Drugs & Pharmaceuticals Limited stock is currently trading at ₹48.5 per share. It touched a 52-week high of ₹53.49 and a 52-week low of ₹53.49. Analysts tracking the stock have a 12-month average target price of .

Its 50-day moving average was ₹41.52 and 200-day moving average was ₹34.41 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 5896% of the company’s stock are held by insiders while 310% are held by institutions.

Frequently Asked Questions About Aarey Drugs & Pharmaceuticals Limited

The stock symbol (also called stock or share ticker) of Aarey Drugs & Pharmaceuticals Limited is 524412

The IPO of Aarey Drugs & Pharmaceuticals Limited took place on

Similar Industry Stocks (Other)

Last Price
Zedge Inc (ZDGE)
B & A Limited (508136)

Most Active

Last Price
Amyris Inc (AMRS)
Humbl Inc (HMBL)

Top Gainers

Last Price
Latch Inc (LTCHW)

Top Losers

Last Price


Aarey Drugs & Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients, bulk drugs, intermediates, and specialty chemicals for various industrial applications in India. The company offers mono methyl and dimethyl urea, theobromine, mefanamic acid, bromomethyl, and dioxolane. It also offers chemicals and solvents, which include aeromatics chemicals, chemical acids, chlor alkalies, glycols and glycol ethers, fiber intermediates, acetates and esters, and chlorinated solvents, as well as industrial alchols, ketones, amines, oleochemicals, intermediates, olefines, phosphates, fertilizers, monomers, and chemicals. The company’s pharmaceutical products are used by pharmaceutical formulation manufacturers and pharmaceutical merchant exporters. It also trades in industrial solvents and chemicals. The company was formerly known as Niharika Textiles & Chemicals Private Limited and changed its name to Aarey Drugs & Pharmaceuticals Limited in March 1993. Aarey Drugs & Pharmaceuticals Limited was incorporated in 1990 and is headquartered in Mumbai, India.


107, 204 Sahakar Bhavan, Mumbai, India, 400009